BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CL-197 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of CL-197\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07308782-1025@assetmemo.bio
DTSTAMP:20261121T004053Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:CL-197: Phase 2 readout est. (NCT07308782)
DESCRIPTION:CL-197\, phase 2\, HIV.\nStudy: A Phase Ⅱa Clinical Study of 
 CL-197 Capsules\nEstimated primary completion: December 2026. This is a Cl
 inicalTrials.gov estimate\, not a confirmed readout date\, and it can move
 .\nDrug page: https://assetmemo.bio/drug/cl-197#upcoming-events\nRegistry 
 record: https://clinicaltrials.gov/study/NCT07308782
URL:https://assetmemo.bio/drug/cl-197#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
